Ten-Year Survival after Multiple Invasive Melanomas Is Worse than after a Single Melanoma: a Population-Based Study

Journal of Investigative Dermatology

Volumn 136, Issue 11, 2016, Pages 2270-2276

  Youlden, Danny R ^a   Baade, Peter D ^a,b,c   Soyer, H Peter ^d,e   Youl, Philippa H ^a,b,c   Kimlin, Michael G ^a,f   Aitken, Joanne F ^a,b   Green, Adele C ^g,h   Khosrotehrani, Kiarash ^d,e,i  

^a CANCER COUNCIL QUEENSLAND   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c GRIFFITH UNIVERSITY   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e PRINCESS ALEXANDRA HOSPITAL   (Australia)

^f UNIVERSITY OF THE SUNSHINE COAST   (Australia)

^g QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^h UNIVERSITY OF MANCHESTER   (United Kingdom)

ⁱ UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER MORPHOLOGY; CANCER PROGNOSIS; CANCER SURVIVAL; CAUSE SPECIFIC SURVIVAL; HUMAN; MELANOMA; PRIORITY JOURNAL; SURVIVAL TIME; TUMOR INVASION; ULCER; ADOLESCENT; CANCER STAGING; CLINICAL TRIAL; EPIDEMIOLOGY; FEMALE; FOLLOW UP; FORECASTING; HEALTH SURVEY; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOLOGY; PROGNOSIS; QUEENSLAND; REGISTER; RETROSPECTIVE STUDY; SKIN TUMOR; SURVIVAL RATE; TRENDS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POPULATION SURVEILLANCE; PROGNOSIS; QUEENSLAND; REGISTRIES; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL RATE; YOUNG ADULT;

EID: 84994779366     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1016/j.jid.2016.03.014     Document Type: Article

References (28)

1. Baade, P.D., Royston, P., Youl, P.H., Weinstock, M.A., Geller, A., Aitken, J.F., Prognostic survival model for people diagnosed with invasive cutaneous melanoma. BMC Cancer, 15, 2015, 27.
2. Balch, C.M., Gershenwald, J.E., Soong, S.J., Thompson, J.F., Atkins, M.B., Byrd, D.R., et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27 (2009), 6199–6206.
3. Bower, M.R., Scoggins, C.R., Martin, R.C. II, Mays, M.P., Edwards, M.J., Reintgen, D.S., et al. Second primary melanomas: incidence and outcome. Am Surg 76 (2010), 675–681.
4. Brandt, A., Sundquist, J., Hemminki, K., Risk of incident and fatal melanoma in individuals with a family history of incident or fatal melanoma or any cancer. Br J Dermatol 165 (2011), 342–348.
5. Brewster, A.M., Alberg, A.J., Strickland, P.T., Hoffman, S.C., Helzlsouer, K., XPD polymorphism and risk of subsequent cancer in individuals with nonmelanoma skin cancer. Cancer Epidemiol Biomarkers Prev 13 (2004), 1271–1275.
6. Burden, A.D., Vestey, J.P., Sirel, J.M., Aitchison, T.C., Hunter, J.A., MacKie, R.M., Multiple primary melanoma: risk factors and prognostic implications. BMJ, 309, 1994, 375.
7. Campbell, P.T., Newton, C.C., Newcomb, P.A., Phipps, A.I., Ahnen, D.J., Baron, J.A., et al. Association between body mass index and mortality for colorectal cancer survivors: overall and by tumor molecular phenotype. Cancer Epidemiol Biomarkers Prev 24 (2015), 1229–1238.
8. Cleaves, M.A., Gould, W.W., Gutierrez, R.G., Marchenko, Y.U., An introduction to survival analysis using Stata. (second edition), 2008, Stata Press, College Station, TX.
9. DeSantis, C.E., Lin, C.C., Mariotto, A.B., Siegel, R.L., Stein, K.D., Kramer, J.L., et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 64 (2014), 252–271.
10. Doubrovsky, A., Menzies, S.W., Enhanced survival in patients with multiple primary melanoma. Arch Dermatol 139 (2003), 1013–1018.
11. Erdmann, F., Lortet-Tieulent, J., Schuz, J., Zeeb, H., Greinert, R., Breitbart, E.W., et al. International trends in the incidence of malignant melanoma 1953–2008—are recent generations at higher or lower risk?. Int J Cancer 132 (2013), 385–400.
12. Kricker, A., Armstrong, B.K., Goumas, C., Thomas, N.E., From, L., Busam, K., et al. Survival for patients with single and multiple primary melanomas: the genes, environment, and melanoma study. JAMA Dermatol 149 (2013), 921–927.
13. Lasithiotakis, K.G., Petrakis, I.E., Garbe, C., Cutaneous melanoma in the elderly: epidemiology, prognosis and treatment. Melanoma Res 20 (2010), 163–170.
14. Li, J., Humphreys, K., Eriksson, L., Edgren, G., Czene, K., Hall, P., Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer. J Clin Oncol 31 (2013), 2249–2256.
15. Matsuura, M., Eguchi, S., Modeling late entry bias in survival analysis. Biometrics 61 (2005), 559–566.
16. Moore, M.M., Geller, A.C., Warton, E.M., Schwalbe, J., Asgari, M.M., Multiple primary melanomas among 16,570 patients with melanoma diagnosed at Kaiser Permanente Northern California, 1996 to 2011. J Am Acad Dermatol 73 (2015), 630–636.
17. Moseley, H.S., Giuliano, A.E., Storm, F.K. 3rd, Clark, W.H., Robinson, D.S., Morton, D.L., Multiple primary melanoma. Cancer 43 (1979), 939–944.
18. Murali, R., Brown, P.T., Kefford, R.F., Scolyer, R.A., Thompson, J.F., Atkins, M.B., et al. Number of primary melanomas is an independent predictor of survival in patients with metastatic melanoma. Cancer 118 (2012), 4519–4529.
19. Nikolaou, V., Stratigos, A.J., Emerging trends in the epidemiology of melanoma. Br J Dermatol 170 (2014), 11–19.
20. Queensland Cancer Registry, Cancer Council Queensland. Cancer in Queensland 1982 to 2012: incidence, mortality, survival and prevalence. 2014, Cancer Council Queensland, Brisbane.
21. Rowe, C.J., Law, M.H., Palmer, J.M., MacGregor, S., Hayward, N.K., Khosrotehrani, K., Survival outcomes in patients with multiple primary melanomas. J Eur Acad Dermatol Venereol 29 (2015), 2120–2127.
22. Royston, P., Lambert, P.C., Flexible parametric survival analysis using stata: beyond the Cox model. 2011, Stata Press, College Station, TX.
23. Savoia, P., Osella-Abate, S., Deboli, T., Marenco, F., Stroppiana, E., Novelli, M., et al. Clinical and prognostic reports from 270 patients with multiple primary melanomas: a 34-year single-institution study. J Eur Acad Dermatol Venereol 26 (2012), 882–888.
24. Scheibner, A., Milton, G.W., McCarthy, W.H., Norlund, J.J., Pearson, L.J., Multiple primary melanoma—a review of 90 cases. Australas J Dermatol 23 (1982), 1–8.
25. Slingluff, C.L. Jr., Vollmer, R.T., Seigler, H.F., Multiple primary melanoma: incidence and risk factors in 283 patients. Surgery 113 (1993), 330–339.
26. Spanogle, J.P., Clarke, C.A., Aroner, S., Swetter, S.M., Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study. J Am Acad Dermatol 62 (2010), 757–767.
27. Youlden, D.R., Khosrotehrani, K., Green, A.C., Soyer, H.P., Youl, P.H., Kimlin, M.K., et al. Diagnosis of an additional in situ melanoma does not influence survival for patients with a single invasive melanoma: a registry-based follow-up study. Australas J Dermatol 57 (2016), 57–60.
28. Youlden, D.R., Youl, P.H., Soyer, H.P., Aitken, J.F., Baade, P.D., Distribution of subsequent primary invasive melanomas following a first primary invasive or in situ melanoma Queensland, Australia, 1982–2010. JAMA Dermatol 150 (2014), 526–534.